Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

NORGESTREL CRS (30 MG)

NORGESTREL CRS (30 MG)

6533-00-2

DISCOVER
Norpseudoephedrine hydrochloride - * psy

Norpseudoephedrine hydrochloride - * psy

2153-98-2

DISCOVER
NORTRIPTYLINE HYDROCHLORIDE CRS (10 MG)

NORTRIPTYLINE HYDROCHLORIDE CRS (10 MG)

894-71-3

DISCOVER
Nicotyrine beta

Nicotyrine beta

487-19-4

DISCOVER
NOSCAPINE CRS (100 MG)

NOSCAPINE CRS (100 MG)

128-62-1

DISCOVER
NYSTATIN CRS (100 MG)

NYSTATIN CRS (100 MG)

1400-61-9

DISCOVER
Nalidixic acid

Nalidixic acid

389-08-2

DISCOVER
Neospiramycin

Neospiramycin

70253-62-2

DISCOVER
Naphazoline HCl

Naphazoline HCl

550-99-2

DISCOVER
N,N-Didesmethylvenlafaxin

N,N-Didesmethylvenlafaxin

93413-77-5

DISCOVER
N-Desmethylvenlafaxin

N-Desmethylvenlafaxin

149289-30-5

DISCOVER
N4-Acetyl-sulfamethoxazol

N4-Acetyl-sulfamethoxazol

21312-10-7

DISCOVER